2nd Quarter - Report

ABBVIE, INC. for ABBVIE INC.

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$970,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
2nd Quarter - Report (this page) Jul 20, 2015 $970,000 Replaced
2nd Quarter - Amendment Oct 19, 2015 $930,000 Yes

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Trans-Atlantic Trade and Investment Partnership; Trans-Pacific Partnership Agreement; Trade Promotion Authority; H.R. 1890 & S. 995, Bipartisan Congressional Trade Priorities and Accountability Act of 2015; Middle East Trade Issues;

LobbyistCovered position, as disclosed
MICHAEL D BOYD —
CATHERINE DRATZ FERGUSON —
JOHN P. FORD —
ANDREW KAPLAN —
HEATHER STRAWN —

Contacted: Patent & Trademark Office (PTO); HOUSE OF REPRESENTATIVES; SENATE; U.S. Trade Representative (USTR); Health & Human Services, Dept of (HHS); State, Dept of (DOS)

Bills named: H.R. 1890 (114th), S. 995 (114th)

Copyright/Patent/Trademark CPT

H.R. 3116, MODDERN Cures Act of 2013; S. 632, STRONG Patents Act of 2015; H.R. 9, Innovation Act; H.R. 160, Protect Medical Innovation Act of 2015; H.R. 971 & S. 1421, Orphan Product Extensions Now Accelerating Cures and Treatments Act of 2015; S. 1137, Protecting American Talent and Entrepreneurship Act of 2015; Proposals/Initiatives related to international intellectual property protection;

LobbyistCovered position, as disclosed
MICHAEL D BOYD —
CATHERINE DRATZ FERGUSON —
JOHN P. FORD —
ANDREW KAPLAN —
STEPHEN SCANGO New —
HEATHER STRAWN —

Contacted: HOUSE OF REPRESENTATIVES; Patent & Trademark Office (PTO); State, Dept of (DOS); U.S. Trade Representative (USTR); Health & Human Services, Dept of (HHS); SENATE

Bills named: H.R. 971 (114th), H.R. 3116 (114th), H.R. 9 (114th), S. 1137 (114th), H.R. 160 (114th), S. 1421 (114th), S. 632 (114th)

Health Issues HCR

H.R. 6, 21st Century Cures Act; Discussions to clarify or reform the 340B program; Biologics Price Competition and Innovation Act; H.R. 2031, TEST Act; H.R. 1101 & S. 1287, Viral Hepatitis Testing Act; Proposals to improve viral hepatitis screening and testing; Public Law 111-148, The Patient Protection and Affordable Care Act; Public Law 111-152, The Health Care and Education Reconciliation Act; Implementation of The Prescription Drug User Fee Act (PDUFA); H.R. 2570 & S. 1396, Value-Based Insurance Design Seniors Copayment Reduction Act of 2015; Proposals to address chronic care coordination; Discussions on international health policy including World Health Organization resolutions;

LobbyistCovered position, as disclosed
MICHAEL D BOYD —
CATHERINE DRATZ FERGUSON —
JOHN P. FORD —
ANDREW KAPLAN —
STEPHEN SCANGO New —
HEATHER STRAWN —

Contacted: SENATE; Health & Human Services, Dept of (HHS); State, Dept of (DOS); HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); Patent & Trademark Office (PTO)

Bills named: H.R. 2031 (114th), H.R. 6 (114th), H.R. 1101 (114th), H.R. 2570 (114th), S. 1396 (114th), S. 1287 (114th)

Medicare/Medicaid MMM

Policies to enhance patient access to medicines in Medicaid; Policies to enhance patient access to medicines in Medicare; H.R. 2298, Medicare Patient Safety and Drug Abuse Prevention Act; H.R. 2914, Promoting Integrity in Medicare Act; S. 141, Protecting Seniors' Access to Medicare Act of 2015 H.R. 2925, Strengthening Medicare Anti-Fraud Measures Act; S. 31, Medicare Prescription Drug Price Negotiation Act of 2015; H.R. 1102 & S. 117, Medicare Prescription Drug Price Negotiation Act; H.R. 2005 & S. 1083, Medicare Drug Savings Act;

LobbyistCovered position, as disclosed
JOHN P. FORD —
ANDREW KAPLAN —
STEPHEN SCANGO New —
HEATHER STRAWN —

Contacted: HOUSE OF REPRESENTATIVES; Patent & Trademark Office (PTO); Health & Human Services, Dept of (HHS); U.S. Trade Representative (USTR); State, Dept of (DOS); SENATE

Bills named: S. 1083 (114th), H.R. 2298 (114th), H.R. 2005 (114th), H.R. 1102 (114th), H.R. 2925 (114th), S. 31 (114th), S. 141 (114th), S. 117 (114th), H.R. 2914 (114th)

Budget/Appropriations BUD

H.R.2029, Military Construction and Veterans Affairs and Related Agencies Appropriations Act; Other Labor, Health and Human Services Appropriations (No Bills Introduced); H.R. 1078, Food & Drug Administration Safety Over Sequestration Act; S. 1413, FDA User Fee Protection Act; FDAs Changes Being Effected Rule;

LobbyistCovered position, as disclosed
CATHERINE DRATZ FERGUSON —
JOHN P. FORD —
ANDREW KAPLAN —
STEPHEN SCANGO New —
HEATHER STRAWN —

Contacted: U.S. Trade Representative (USTR); Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES; Patent & Trademark Office (PTO); State, Dept of (DOS)

Bills named: H.R. 1078 (114th), S. 1413 (114th), H.R. 2029 (114th)

Taxation/Internal Revenue Code TAX

H.R. 880, American Research and Competitiveness Act of 2015; H.R. 1430, Permanent CFC Look-Through Act; Administrations Tax Reform and 2015 Budget Proposals; Senate and House Committee Tax Reform Proposals; Proposals to reform domestic and international tax structures (no bills introduced);

LobbyistCovered position, as disclosed
MICHAEL D BOYD —
ANDREW KAPLAN —
HEATHER STRAWN —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Patent & Trademark Office (PTO); U.S. Trade Representative (USTR); State, Dept of (DOS); SENATE

Bills named: H.R. 1430 (114th), H.R. 880 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.